array(3) { ["company_details"]=> array(13) { ["name"]=> string(25) "ROCHE DIAGNOSTICS LIMITED" ["slug"]=> string(34) "ef866-gb-roche-diagnostics-limited" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/5ce04174-8fff-4069-9bd1-2ef80ada854c" ["description"]=> string(1583) "Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com/global/en Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation" ["address_street"]=> string(14) "Charles Avenue" ["address_place"]=> string(12) "BURGESS HILL" ["address_region"]=> NULL ["founding_date"]=> string(10) "1956-09-14" ["website_domain"]=> string(9) "roche.com" ["website_url"]=> string(29) "https://diagnostics.roche.com" ["industry_codes"]=> array(1) { [0]=> string(43) "Business Services, Not Elsewhere Classified" } ["employee_count"]=> int(658) ["article_count"]=> int(3435) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(163) "Stock market ticker: Swiss stock exchange directionless before ECB interest rate decision - Analyst sees financial stocks 16 percent higher - Six new price targets" ["snippet_en"]=> string(58) "The Swiss stock market was holding up on Thursday morning." ["url"]=> string(182) "https://www.cash.ch/news/top-news/borsen-ticker-smi-vorborslich-hoher-givaudan-und-vat-im-mittelpunkt-inflationsdaten-vergraulen-anleger-an-der-wall-street-zwei-neue-kursziele-701298" ["image_url"]=> string(78) "https://images.businessradar.com/articles/f5e8205d-9bf4-450d-ac68-118781d49f39" ["source"]=> string(7) "cash.ch" ["publication_date"]=> string(10) "2024-04-11" ["categories"]=> array(5) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(12) "Stock Market" [2]=> string(15) "Market Movement" [3]=> string(12) "Going Public" [4]=> string(18) "General Investment" } } [1]=> array(7) { ["title_en"]=> string(52) "JPMORGAN upgrades ROCHE HOLDINGS AG to 'Underweight'" ["snippet_en"]=> string(273) "April 5, 2024 - The US bank JPMorgan has left the rating for Roche at 'Underweight' with a price target of 210 francs ahead of figures for the first quarter. The pharmaceutical company is likely to fall slightly short of market expectations, wrote analyst Richard Vosser..." ["url"]=> string(96) "https://www.wallstreet-online.de/nachricht/17956414-jpmorgan-stuft-roche-holdings-ag-underweight" ["image_url"]=> string(78) "https://images.businessradar.com/articles/bea16ee2-e486-4e03-8a9a-7c722a3622d3" ["source"]=> string(20) "wallstreet-online.de" ["publication_date"]=> string(10) "2024-04-05" ["categories"]=> array(4) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(24) "Stock Research & Ratings" [2]=> string(31) "Financial Update/Profit Warning" [3]=> string(12) "Stock Market" } } [2]=> array(7) { ["title_en"]=> string(60) "Research conclusions on Roche, Air Liquide, Amazon, Meta ..." ["snippet_en"]=> string(197) "Research conclusions on Roche Air Liquide Amazon Meta ... - BARCLAYS RAISES TARGET FOR ASM INTERNATIONAL TO 575,530 EUR 'EQUAL WEIGHT' RECKITT 6100 6000 PENCE 'OVERWEIGHT'- LOWERS ROCHE 230,250 CHF" ["url"]=> string(85) "https://boerse-social.com/2024/04/25/research-fazits_zu_roche_air_liquide_amazon_meta" ["image_url"]=> string(78) "https://images.businessradar.com/articles/29de8741-9792-468c-8443-1f84e0db80c9" ["source"]=> string(17) "boerse-social.com" ["publication_date"]=> string(10) "2024-04-02" ["categories"]=> array(3) { [0]=> string(5) "R & D" [1]=> string(17) "Academic Research" [2]=> string(24) "Stock Research & Ratings" } } [3]=> array(7) { ["title_en"]=> string(63) "Roche shares fall: JPMorgan analyst cuts price target for Roche" ["snippet_en"]=> string(65) "JPMorgan Chase & Co. issues this recommendation for Roche shares." ["url"]=> string(138) "https://www.finanzen.ch/nachrichten/aktien/jp-morgan-chase-co-veroeffentlicht-investment-empfehlung-roche-aktie-mit-underweight-1033086196" ["image_url"]=> string(78) "https://images.businessradar.com/articles/53605eb9-73e4-4879-bf90-a82c5eecab02" ["source"]=> string(11) "finanzen.ch" ["publication_date"]=> string(10) "2024-02-21" ["categories"]=> array(6) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(12) "Stock Market" [2]=> string(15) "Market Movement" [3]=> string(14) "Issuing Shares" [4]=> string(18) "General Investment" [5]=> string(16) "Share Repurchase" } } [4]=> array(7) { ["title_en"]=> string(80) "Roche remains trapped in the downward spiral - analyst lowers price target again" ["snippet_en"]=> string(162) "Once again, the JPMorgan analyst reaches for the red pencil and significantly reduces the price target. This is his fifth price target reduction within 14 months." ["url"]=> string(114) "https://www.cash.ch/news/top-news/roche-bleibt-in-der-abwartsspirale-gefangen-analyst-senkt-kursziel-erneut-685695" ["image_url"]=> string(78) "https://images.businessradar.com/articles/47c3df88-d804-4aba-b67e-718b60fffdc8" ["source"]=> string(7) "cash.ch" ["publication_date"]=> string(10) "2024-02-21" ["categories"]=> array(3) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(12) "Stock Market" } } [5]=> array(7) { ["title_en"]=> string(171) "Stock market ticker: Swiss stock exchange with a negative trend - Temenos in focus in the evening - JPMorgan analyst sees Sika 11 percent lower - public holiday in the USA" ["snippet_en"]=> string(122) "After the good performance of the previous week, the Swiss stock market started the new trading week cautiously on Monday." ["url"]=> string(139) "https://www.cash.ch/news/top-news/borsen-ticker-smi-vorborslich-tiefer-durchzogene-us-vorgaben-vom-freitag-temenos-am-abend-im-fokus-684871" ["image_url"]=> string(78) "https://images.businessradar.com/articles/7614b4ea-67ca-4a59-9a7a-f8735b4ed6c9" ["source"]=> string(7) "cash.ch" ["publication_date"]=> string(10) "2024-02-19" ["categories"]=> array(12) { [0]=> string(21) "Shareholders Feedback" [1]=> string(24) "Stock Research & Ratings" [2]=> string(12) "Stock Market" [3]=> string(20) "Corporate Governance" [4]=> string(18) "Ecological Impacts" [5]=> string(18) "Activist Investors" [6]=> string(15) "Market Movement" [7]=> string(6) "Merger" [8]=> string(12) "Going Public" [9]=> string(18) "General Investment" [10]=> string(24) "Quarterly/Annual Figures" [11]=> string(11) "Acquisition" } } [6]=> array(7) { ["title_en"]=> string(52) "JPMORGAN upgrades ROCHE HOLDINGS AG to 'Underweight'" ["snippet_en"]=> string(205) "NEW YORK (dpa-AFX Analyzer) - The US bank JPMorgan has left the rating for Roche at "Underweight" with a price target of 230 francs according to half-year figures. In terms of core operating results (EBIT)" ["url"]=> string(118) "https://www.finanznachrichten.de/nachrichten-2024-02/61291468-jpmorgan-stuft-roche-holdings-ag-auf-underweight-322.htm" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a927213a-51a1-4b8a-87da-15bb5d3df998" ["source"]=> string(20) "finanznachrichten.de" ["publication_date"]=> string(10) "2024-02-01" ["categories"]=> array(3) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(24) "Stock Research & Ratings" [2]=> string(12) "Stock Market" } } [7]=> array(7) { ["title_en"]=> string(108) "Stock market ticker: Swiss stock exchange without direction - Givaudan with a price gain of almost 8 percent" ["snippet_en"]=> string(84) "The Swiss stock exchange closed just in the black on the second-to-last trading day." ["url"]=> string(153) "https://www.cash.ch/news/top-news/borsen-ticker-smi-gibt-vor-ezb-zinsentscheid-nach-nestle-auf-2020-niveau-givaudan-im-aufwind-zehn-neue-kursziele-676997" ["image_url"]=> string(78) "https://images.businessradar.com/articles/d8728946-c400-408f-bfc6-d910a24a9563" ["source"]=> string(7) "cash.ch" ["publication_date"]=> string(10) "2024-01-25" ["categories"]=> array(14) { [0]=> string(11) "Sponsorship" [1]=> string(13) "Credit Rating" [2]=> string(31) "Financial Update/Profit Warning" [3]=> string(24) "Stock Research & Ratings" [4]=> string(12) "Stock Market" [5]=> string(21) "Competitive Behaviour" [6]=> string(15) "Market Movement" [7]=> string(20) "Contract negotiation" [8]=> string(9) "Investors" [9]=> string(21) "Financial Performance" [10]=> string(12) "Going Public" [11]=> string(24) "Access and affordability" [12]=> string(24) "Quarterly/Annual Figures" [13]=> string(19) "Economic Conditions" } } [8]=> array(7) { ["title_en"]=> string(156) "Stock market ticker: SMI gives in before ECB interest rate decision - Nestlé at 2020 level - Analyst sees Logitech 21 percent lower - Ten new price targets" ["snippet_en"]=> string(66) "The Swiss stock market fell slightly in early trading on Thursday." ["url"]=> string(169) "https://www.cash.ch/news/top-news/borsen-ticker-smi-vorborslich-tiefer-wieder-rekorde-an-der-wall-street-microsoft-setzt-hohenflug-fort-ezb-zinsentscheid-im-fokus-676997" ["image_url"]=> string(78) "https://images.businessradar.com/articles/73937f60-7b68-42d7-8c80-07b6e8c94c8d" ["source"]=> string(7) "cash.ch" ["publication_date"]=> string(10) "2024-01-25" ["categories"]=> array(8) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(12) "Stock Market" [2]=> string(21) "Competitive Behaviour" [3]=> string(15) "Market Movement" [4]=> string(9) "Investors" [5]=> string(18) "Financial Distress" [6]=> string(24) "Quarterly/Annual Figures" [7]=> string(19) "Economic Conditions" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(217) } [1]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(204) } [2]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(192) } [3]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(156) } [4]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(153) } [5]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(148) } [6]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(137) } [7]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(136) } [8]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(111) } [9]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(105) } [10]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(102) } [11]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(97) } [12]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(92) } [13]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(89) } [14]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(86) } [15]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(69) } [16]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(65) } [17]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(64) } [18]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(62) } [19]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(49) } [20]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(42) } [21]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(40) } [22]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(39) } [23]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(38) } [24]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(33) } [25]=> array(2) { ["name"]=> string(12) "Staff hiring" ["count"]=> int(33) } [26]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(32) } [27]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(32) } [28]=> array(2) { ["name"]=> string(7) "Layoffs" ["count"]=> int(32) } [29]=> array(2) { ["name"]=> string(16) "Customer Welfare" ["count"]=> int(32) } } } ef866-gb-roche-diagnostics-limited